Pluri Inc. SEC filings PLUR
Pluri Inc. has 953 filings in SEC EDGAR's recent list, going back to Sep 10, 2001. Its latest annual report, Form 10-K, was filed on Sep 10, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (material agreement, unregistered share sale, other events). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 30, 2026 | Oct 21, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 27, 2026 | — |
| 4 | Insider transaction | Oct 27, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 20, 2026 | Oct 19, 2026 |
| EFFECT | Filing | Oct 15, 2026 | — |
| S-1 | Registration statement | Oct 6, 2026 | — |
| S-3 | Shelf registration | Sep 11, 2026 | — |
| S-8 | Employee stock plan registration | Sep 11, 2026 | — |
| S-8 | Employee stock plan registration | Sep 11, 2026 | — |
| 10-K | Annual report | Sep 10, 2026 | Jun 30, 2026 |
| D | Filing | Sep 4, 2026 | — |
| 424B5 | Prospectus supplement | Aug 28, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 28, 2026 | Aug 26, 2026 |
| 424B3 | Prospectus | Aug 27, 2026 | — |
| 4 | Insider transaction | Aug 24, 2026 | Aug 20, 2026 |
| 4 | Insider transaction | Aug 24, 2026 | Aug 20, 2026 |
| 8-K |
Current report
Other events
|
Aug 17, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Other events
|
Jul 14, 2026 | Jul 14, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 13, 2026 | Jul 7, 2026 |
| 3 | Initial insider ownership | Jul 7, 2026 | Jun 19, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 1, 2026 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Shareholder vote results
|
Jun 22, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Other events
|
Jun 1, 2026 | May 28, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | May 4, 2026 | Mar 31, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 1, 2026 | — |
| ARS | Annual report to shareholders | Apr 23, 2026 | Jun 30, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 27, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Other events
|
Mar 2, 2026 | Feb 27, 2026 |
| 10-Q | Quarterly report | Feb 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 22, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 30, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 5, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 15, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Dec 9, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Nov 20, 2025 | Oct 29, 2025 |
| 4 | Insider transaction | Nov 13, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 16, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2025 | Oct 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 14, 2025 | — |
| EFFECT | Filing | Sep 25, 2025 | — |
| CORRESP | Letter to the SEC | Sep 23, 2025 | — |
| 3 | Initial insider ownership | Sep 22, 2025 | Sep 10, 2025 |
| UPLOAD | Letter from the SEC | Sep 22, 2025 | — |
| S-3 | Shelf registration | Sep 17, 2025 | — |
| S-8 | Employee stock plan registration | Sep 17, 2025 | — |
| S-8 | Employee stock plan registration | Sep 17, 2025 | — |
| 10-K | Annual report | Sep 17, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Sep 12, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Listing notice, Officer or director change, Shareholder vote results
|
Jul 3, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Apr 28, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 9, 2025 | — |
| UPLOAD | Letter from the SEC | May 28, 2025 | — |
| ARS | Annual report to shareholders | May 27, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | May 27, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
May 27, 2025 | May 21, 2025 |
| CORRESP | Letter to the SEC | May 21, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 20, 2025 | — |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 12, 2025 | — |
| 8-K |
Current report
Other events
|
May 8, 2025 | May 7, 2025 |
| 8-K | Current report | Apr 29, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Other events
|
Apr 28, 2025 | Apr 28, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 25, 2025 | May 23, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 25, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Other events
|
Apr 17, 2025 | Apr 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 16, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2025 | — |
| CORRESP | Letter to the SEC | Apr 3, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2025 | — |
| CORRESP | Letter to the SEC | Mar 27, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 26, 2025 | — |
| D | Filing | Mar 19, 2025 | — |
| 8-K | Current report | Mar 19, 2025 | Mar 13, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 13, 2025 | Mar 12, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 3 | Initial insider ownership | Feb 18, 2025 | Feb 5, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 12, 2025 | — |
| 10-Q | Quarterly report | Feb 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 6, 2025 | Feb 3, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 4, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Jan 29, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 21, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Listing notice
|
Nov 27, 2024 | Nov 25, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Oct 1, 2024 | Sep 26, 2024 |
| 3 | Initial insider ownership | Sep 30, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 18, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 18, 2024 |
| 10-K | Annual report | Sep 18, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 23, 2024 | Jul 19, 2024 |
| 8-K |
Current report
Other events
|
Jul 8, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Material agreement
|
Jun 18, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Listing notice
|
May 31, 2024 | May 28, 2024 |
| S-8 | Employee stock plan registration | May 9, 2024 | — |
| S-8 | Employee stock plan registration | May 9, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | May 1, 2024 | Jun 30, 2023 |
| DEF 14A | Proxy statement | May 1, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Other events
|
Apr 17, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Apr 1, 2024 | Mar 27, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 424B5 | Prospectus supplement | Feb 13, 2024 | — |
| 8-K |
Current report
Material agreement
|
Feb 13, 2024 | Feb 13, 2024 |
| 10-Q | Quarterly report | Feb 12, 2024 | Dec 31, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 1, 2024 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 29, 2024 | — |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 8-K |
Current report
Other events
|
Jan 24, 2024 | Jan 23, 2024 |
| 8-K |
Current report
Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Listing notice
|
Oct 19, 2023 | Oct 17, 2023 |
| EFFECT | Filing | Sep 21, 2023 | — |
| CORRESP | Letter to the SEC | Sep 19, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 15, 2023 | — |
| S-3/A | Amendment no. 1 to form s-3 | Sep 12, 2023 | — |
| 10-K | Annual report | Sep 12, 2023 | Jun 30, 2023 |
| UPLOAD | Letter from the SEC | Jul 25, 2023 | — |
| S-3 | Shelf registration | Jul 20, 2023 | — |
| 4 | Insider transaction | Jul 13, 2023 | Jul 11, 2023 |
| 3 | Initial insider ownership | Jul 13, 2023 | Jul 11, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2023 | Jul 11, 2023 |
| 8-K |
Current report
Other events
|
Jul 11, 2023 | Jul 11, 2023 |
| EFFECT | Filing | Jun 8, 2023 | — |
| CORRESP | Letter to the SEC | Jun 6, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 5, 2023 | — |
| S-3 | Shelf registration | Jun 1, 2023 | — |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Apr 27, 2023 | Apr 27, 2023 |
| 8-K |
Current report
Listing notice
|
Apr 25, 2023 | Apr 19, 2023 |
| ARS | Annual report to shareholders | Feb 27, 2023 | Jun 30, 2022 |
| DEF 14A | Proxy statement | Feb 27, 2023 | Apr 27, 2023 |
| PRE 14A | Preliminary proxy statement | Feb 16, 2023 | Feb 16, 2023 |
| SC 13G | Ownership over 5% (passive) | Feb 16, 2023 | — |
| 8-K/A | Amended current report | Feb 14, 2023 | Feb 6, 2023 |
| S-8 | Employee stock plan registration | Feb 13, 2023 | — |
| S-8 | Employee stock plan registration | Feb 13, 2023 | — |
| 10-Q | Quarterly report | Feb 13, 2023 | Dec 31, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2023 | — |
| 8-K | Current report | Feb 6, 2023 | Feb 6, 2023 |
| 8-K |
Current report
Other events
|
Jan 24, 2023 | Jan 23, 2023 |
| SC 13D | Ownership over 5% (active) | Jan 4, 2023 | — |
| D | Filing | Dec 30, 2022 | — |
| 8-K |
Current report
Other events
|
Dec 28, 2022 | Dec 22, 2022 |
| 4 | Insider transaction | Dec 22, 2022 | Dec 22, 2022 |
| 4 | Insider transaction | Dec 22, 2022 | Dec 20, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Dec 19, 2022 | Dec 13, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Listing notice
|
Oct 13, 2022 | Oct 12, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 29, 2022 | Sep 29, 2022 |
| 424B5 | Prospectus supplement | Sep 21, 2022 | — |
| 10-K | Annual report | Sep 21, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 25, 2022 | Jul 22, 2022 |
| 8-K |
Current report
Other events
|
Jul 13, 2022 | Jul 13, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 23, 2022 | Jun 21, 2022 |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 21, 2022 |
| 8-K |
Current report
Other events
|
Mar 24, 2022 | Mar 23, 2022 |
| 8-K |
Current report
Other events
|
Mar 8, 2022 | Mar 8, 2022 |
| 8-K |
Current report
Other events
|
Feb 28, 2022 | Feb 24, 2022 |
| 4 | Insider transaction | Feb 14, 2022 | Feb 10, 2022 |
| 10-Q | Quarterly report | Feb 7, 2022 | Dec 31, 2021 |
| SC 13G | Ownership over 5% (passive) | Jan 26, 2022 | — |
| 8-K |
Current report
Material agreement
|
Jan 10, 2022 | Jan 5, 2022 |
| 8-K |
Current report
Other events
|
Jan 3, 2022 | Jan 1, 2022 |
| 8-K |
Current report
Other events
|
Dec 27, 2021 | Dec 27, 2021 |
| 8-K |
Current report
Other events
|
Nov 16, 2021 | Nov 15, 2021 |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| 10-K | Annual report | Sep 13, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jul 26, 2021 | Jul 15, 2021 |
| 4 | Insider transaction | Jul 26, 2021 | Jul 15, 2021 |
| 3 | Initial insider ownership | Jul 26, 2021 | Jul 15, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PLUR (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- NV
- Headquarters
- Haifa
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1158780
- Former names
- PLURISTEM THERAPEUTICS INC (until Jul 13, 2022); PLURISTEM LIFE SYSTEMS INC (until Dec 28, 2007); AI SOFTWARE INC (until Jul 1, 2003)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.